Elevation of serum anti–glucose-regulated protein 78 antibodies in neuropsychiatric systemic lupus erythematosus

Elevation of serum anti–glucose-regulated protein 78 antibodies in neuropsychiatric systemic lupus erythematosus
复制标题

神经精神系统性红斑狼疮血清抗葡萄糖调节蛋白78抗体升高

DOI:
--
复制
发表时间:
2018
影响因子:
3.9
通讯作者:
S. Hirohata
S. Hirohata
中科院分区:
医学3区
文献类型:
--
作者:
Y. Matsueda;Y. Arinuma;T. Nagai;S. Hirohata

文献摘要

被引文献

相似文献

目的近年来的研究表明,内皮细胞上针对葡萄糖调节蛋白78(GRP 78)的自身抗体可促进血脑屏障(BBB)的损伤。本研究探讨血清抗GRP 78抗体是否可能参与神经精神系统性红斑狼疮(NPSLE)的发病机制。方法收集129例SLE患者(弥漫性NPSLE患者58例,局灶性NPSLE患者30例,狼疮性肾炎(LN)患者21例,单纯SLE患者20例)、35例非SLE风湿性疾病患者(non-SLE RD)和24例健康对照者(HC)的血清标本。使用重组GRP 78作为抗原,用ELISA测量抗GRP 78水平。还从88例NPSLE患者中获得脑脊液(CSF)样本。采用Q白蛋白(CSF白蛋白/血清白蛋白)×103评价血脑屏障功能。结果SLE患者血清抗GRP 78抗体水平显著高于非SLE RD或HC患者。血清抗GRP 78水平在NPSLE、LN和SLE之间无显著差异。值得注意的是,急性意识模糊状态(ACS)中的血清抗GRP 78水平显著高于非ACS弥漫性NPSLE(p=0.0001)或局灶性NPSLE(p=0.0002)。最后,血清抗GRP 78水平与Q白蛋白在NPSLE中显著相关(r=0.294,p=0.0054)。结论抗GRP 78抗体与弥漫性NPSLE尤其是ACS的发生有关。因此,这些数据表明,抗GRP 78抗体可能通过BBB的损伤而促进ACS的发展。
Objective Recent studies have demonstrated that autoantibodies directed against glucose-regulated protein 78 (GRP78) on endothelial cells promote blood–brain barrier (BBB) damages. The present study examined whether serum anti-GRP78 antibodies might be involved in the pathogenesis of neuropsychiatric SLE (NPSLE). Methods Serum samples were obtained from 129 patients with SLE (58 patients with diffuse psychiatric/neuropsychological syndromes of NPSLE (diffuse NPSLE), 30 with neurological syndromes (focal NPSLE), 21 with lupus nephritis (LN), 20 without NPSLE or LN (SLE alone)), from 35 patients with non-SLE rheumatic diseases (non-SLE RD) and from 24 healthy controls (HC). Anti-GRP78 levels were measured with an ELISA, using recombinant GRP78 as antigens. Cerebrospinal fluid (CSF) samples were also obtained from 88 patients with NPSLE. The BBB function was evaluated by Q albumin ((CSF albumin/serum albumin)×103). Results Serum anti-GRP78 levels were significantly elevated in SLE compared with non-SLE RD or HC. There were no significant differences in serum anti-GRP78 levels among NPSLE, LN and SLE alone. Of note, serum anti-GRP78 levels were significantly higher in acute confusional state (ACS) than in non-ACS diffuse NPSLE (p=0.0001) or in focal NPSLE (p=0.0002). Finally, serum anti-GRP78 levels were significantly correlated with Q albumin (r=0.294, p=0.0054) in NPSLE. Conclusion These results indicate that anti-GRP78 antibodies are associated with the development of diffuse NPSLE, especially ACS. Thus, the data suggest that anti-GRP78 antibodies might contribute to the development of ACS through the damages of BBB.